2271 - 2280 of 6422 Results
Title
Year
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/journals/communication/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 8
-
OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 42
-
OPENTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 12
-
OPENTitle: Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cellsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 147Issue #:Start Page: 105070End Page: 105070Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2021.105070Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7610942Citation Count: 23
-
OPENTitle: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 133Issue #: 1Start Page: 109End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012Citation Count: 3
-
OPENTitle: A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid BindingJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 433Issue #: 24Start Page: 167323End Page: 167323Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2021.167323Citation Count: 12
-
OPENTitle: Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementiaJournal Name: Psychiatry and Clinical NeurosciencesPublisher: WileyVol: 79Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/pcn.13810Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/pcn.13810Citation Count: 1
- Anatomical abnormalities suggest a compensatory role of the cerebellum in early Parkinson's disease2025OPENTitle: Anatomical abnormalities suggest a compensatory role of the cerebellum in early Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 310Issue #:Start Page: 121121End Page: 121121Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2025.121121Best OA location URL: https://doi.org/10.1016/j.neuroimage.2025.121121Citation Count: 2
-
OPENTitle: Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 12Issue #: 6Start Page: 100133End Page: 100133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100133Best OA location URL: https://doi.org/10.1016/j.tjpad.2025.100133Citation Count: 1
-
OPENTitle: A Novel Longitudinal Rank-Sum Test for Multiple Primary Endpoints in Clinical Trials: Applications to Neurodegenerative DisordersJournal Name: Statistics in Biopharmaceutical ResearchPublisher: Informa UK LimitedVol: 17Issue #: 4Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/19466315.2025.2458018Citation Count: 2